The impact of congenital heart disease on treatment and survival of patients with hepatoblastoma: A single-center experience.

ABSTRACT:

Background

Patients with hepatoblastoma (HB) have a higher risk of congenital heart defects (CHD). There is limited literature on the management and outcomes of these patients. The purpose of this study was to identify demographics and outcomes of these patients in a single tertiary referral center.

Methods

An Institutional Review Board (IRB)-approved retrospective chart review of patients with newly diagnosed HB from October 2004 to January 2021 was performed. CHD was defined as the presence of a septal defect, patent ductus arteriosus, pulmonary atresia, or bicuspid aortic valve. Chi-square and t-test were utilized for statistical analyses.

Results

Of the 151 patients diagnosed with HB during the study timeframe, 29 patients were found to have CHD. Five-year overall

SUBMITTER: Espinoza AF 

PROVIDER: S-EPMC11464190 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature